Valsartan And Hydrochlorothiazide
Product Images NDC 50090-3485

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-3485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903485)

Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablet bottle label by A-S Medication Solutions. This packaging contains 90 tablets with each film-coated tablet comprising 320 mg valsartan USP and 12.5 mg hydrochlorothiazide USP. Storage instructions recommend keeping the bottle at 77 degrees Fahrenheit and protecting from moisture.*

FDA Label Image

Figure 1 (Valsahctz Figur1)

A line graph showing the probability of achieving systolic blood pressure (SBP) below 140 mmHg at Week 8 for different treatments. The x-axis represents baseline SBP (mmHg) from 140 to 180, and the y-axis shows the percentage achieving SBP <140 mmHg from 0 to 100%. Curves compared include Valsartan and hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, with the combination treatment showing the highest probability across baseline SBP values.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Three line graphs illustrating the probability of achieving specific blood pressure targets at week 8 with Valsartan and Hydrochlorothiazide tablets 320/25 mg compared to Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The graphs show probabilities for diastolic blood pressure (DBP) <90 mmHg, systolic blood pressure (SBP) <130 mmHg, and DBP <80 mmHg, plotted against baseline DBP or SBP values in mmHg.*

FDA Label Image

Structure (Valsahctz Hctz)

Chemical structure of the active ingredient shown in the image, depicting a chlorinated benzene ring with sulfonamide and imidazoline functional groups. The image is labeled as part of the Valsartan and Hydrochlorothiazide product set.*

FDA Label Image

Structure (Valsahctz Valsa)

Chemical structure diagram of Valsartan, an active ingredient in the medication Valsartan and Hydrochlorothiazide. The image depicts the molecular arrangement of the compound's atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.